YM BioSciences’ EGFr antibody receives EU orphan drug designation through Oncoscience AG, its European partner

Oncoscience | August 10th, 2004

10.08.2004 – Mississauga. YM BioSciences Inc., the cancer drug development company with an advanced-stage portfolio, ...